. 2010 Mar;26(3):293–300. doi: 10.1089/aid.2009.0082

Table 1.

Clinical Characteristics of the Patients Analyzed in This Study Stratified by Failure or Success of NVP-Containing ART after sdNVP Exposure

	ART failures (n = 7)	Controls (n = 19)	p Value^a
CD4 count (cells/μl) at HAART initiation, median (IQR)^b	51 (46–84)^c	179 (156–231)^d	0.001
Viral load (RNA copies/log₁₀) at HAART initiation, median (IQR)^b	5.31 (4.91–5.88)	4.90 (4.57–5.5)	0.19
Months after delivery before starting HAART, median (IQR)	5.5 (3.75–8.63)	9.5 (7–13.56)	0.09
Months to failure or duration of follow-up, median	6 (5.5–6.6)	31 (24.13–42.69)	—

^{^a}

p-value by Wilcoxon rank sum test.

^{^b}

CD4 count and viral load are from samples immediately prior to antiretroviral therapy. IQR, interquartile range.

^{^c}

One value missing.

^{^d}

Two values missing.